Overview

C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression

Status:
Withdrawn
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
This study will investigate how well Carbon Acetate PET/CT imaging helps to correctly identify recurrent tumor versus post treatment effects (radionecrosis) in patients with previously treated high grade brain gliomas.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Phoenix Molecular Imaging